Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 1028

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 1028
---
 without limitation, any representation required herein, extend any applicable deadlines under these Bylaws or enable or be deemed to permit a stockholder who has previously submitted a stockholder’s notice under these Bylaws to
change any representation that was previously made pursuant to this Section 2.7, to amend or update any proposal or to submit any new proposal, including by changing or adding nominees, matters, business and/or resolutions proposed to be
brought before a meeting of stockholders.

(f) . This
shall not apply to a proposal proposed to be made by a stockholder if the stockholder has notified the Corporation of the stockholder’s intention to present the proposal at an annual or special meeting only
pursuant to and in compliance with Rule 14a-8 under the Exchange Act and such proposal has been included in a proxy statement that has been prepared by the Corporation to solicit proxies for such meeting.

(g) In addition to the provisions of this , a stockholder shall also comply with all of the applicable
requirements of the Exchange Act and the rules and regulations thereunder with respect to the matters set forth herein. Nothing in this , including, without limitation, Section, shall be
deemed to affect any rights of the holders of Preferred Stock to elect directors pursuant to the Certificate of Incorporation.

(h)
Notwithstanding anything in to the contrary, in the event that the number of directors is increased and there is no Public Disclosure of the appointment of a director, or, if no appointment was made, of the
vacancy, made by the Corporation at least 10 days before the last day a stockholder may deliver a notice of nomination in accordance with , a stockholder’s notice required by this
and which complies with the requirements in , other than the timing requirements in , shall also be considered timely, but only
with respect to nominees for any new positions created by such increase, if it is received by the Secretary at the principal executive offices of the Corporation not later than the close of business on the 10th day following the day on which such
Public Disclosure is first made by the Corporation.

Section2.8. Conduct of Meetings. The chair of each
annual and special meeting of stockholders shall be the Chair of the Board or, in the absence (or inability or refusal to act) of the Chair of the Board, the Chief Executive Officer (if he or she shall be a director) or, in the absence (or inability
or refusal to act of the Chief Executive Officer or if the Chief Executive